This is an active lawsuit.


Elmiron


Pentosan Polysulfate sodium or elmiron is a medication used to treat discomfort and pain associated with interstitial cystitis (IC). Interstitial cystitis is a chronic heath condition that causes pressure and pain in the bladder.

Elmiron is currently the only oral prescription drug approved to treat discomfort associated with IC, with woman being the most common long-term user.

The medication elmiron does not cure interstitial cystitis, rather researchers believe pentosan polysulfate sodium protects the bladder from irritants found in the urine rather than stopping inflammation like Tylenol or ibuprofen.

While the most common side effects (including headache, hair loss, and diarrhea) only occurred in up to 4% of participants, elmiron lawsuits claim the medication could be toxic to the retina, light sensing tissue behind the eye.

Elmiron current does not list any warning pertaining to eye damage or the risk of eye disease, yet studies suggest the medication does contribute to vision problems in consumers.



This is an active lawsuit.






Related Injuries

Retinopathy
Vision impairment
Eye disease
Blurred vision
Maculopathy
Blindness



Lawsuit Qualifications

Research has shown patients taking elmiron showed signs for toxicity as a result of the anti-pain pill.

Elmiron lawsuits accuse the medication's manufacturers of failing to properly warn consumers of the potential for eye and vision problems.

Lawyers are looking for individuals who have taken the medication elmiron only to later experience vision and eye problems including retinopathy, vision impairment, eye disease, and maculopathy.

If you or a loved one took elmiron and were later diagnosed with eye disease or vision lost you may qualify for this active lawsuit. Thousands of people have taken elmiron and may have been exposed to permanent vision loss.



About Us

We in no way claim to be legal or medical professionals. Rather, we connect you with a lawyer who can help you file a lawsuit on a contingency-fee-basis, so you pay nothing out of pocket for their services.

Simply file a claim below and we'll connect you with a qualified lawyer who will review your case to see if you qualify for legal compensation.



Elmiron

(Image: drugwatch.com)

Elmiron Facts

  • Usage

    Discomfort or pain from bladder pain syndrome or interstitial cystitis (IC)

  • Manufacturers

    Janssen Pharmaceuticals
    Johnson & Johnson

  • INJURIES CLAIMED IN LAWSUITS

    Retinopathy
    Vision impairment
    Eye disease
    Blurred vision
    Maculopathy
    Blindness

Please seek the advice of a medical professional before making health care decisions.





See if you qualify for the Elmiron Lawsuit

All information is sent to a qualified law firm who ultimately determines if you qualify for the claim.

Basic medical history

Answer the questions below regarding your family's medical history.

Injured Party Contact Information

Contact information so the can get in contact and provide the status of your claim.

Contact Time

Please let us know when it is best for an attorney to reach you.

Terms & Conditions | Privacy Policy - Submission of this form does not guarantee you will qualify for the claim and/or be added to the active lawsuit. After submission, you will be contacted by a trusted legal partner who will determine if you qualify for the lawsuit. This is a legal advertisement.

https://www.levinlaw.com/elmiron-lawsuit
http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/ELMIRON-pi.pdf?
https://www.ic-network.com/long-term-pentosan-elmiron-use-may-be-linked-to-retinal-disease/
https://www.rxlist.com/elmiron-side-effects-drug-center.htm
https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-public-dashboard
https://www.healio.com/ophthalmology/journals/osli/2019-10-50-10/%7B324bde2e-2389-4815-bf5e-fe3b2eb18062%7D/progressive-maculopathy-after-discontinuation-of-pentosan-polysulfate-sodium
https://rosemark.net/wp-content/uploads/2015/11/interstitial-cystitis-information.pdf